Cargando…

May IL-17 have a role in COVID-19 infection?

Detalles Bibliográficos
Autores principales:	Megna, Matteo, Napolitano, Maddalena, Fabbrocini, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175896/ https://www.ncbi.nlm.nih.gov/pubmed/32339777 http://dx.doi.org/10.1016/j.mehy.2020.109749

Ejemplares similares

May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions?
por: Marasca, Claudio, et al.
Publicado: (2020)

Risankizumab treatment in psoriasis patients who failed anti‐IL17: A 52‐week real‐life study
por: Megna, Matteo, et al.
Publicado: (2022)

Treatment of Atopic Dermatitis with Biologic Drugs
por: Fabbrocini, Gabriella, et al.
Publicado: (2018)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab
por: Megna, Matteo, et al.
Publicado: (2022)

Neutrophilic Dermatosis in Pregnancy: An Uncommon Course
por: Villani, Alessia, et al.
Publicado: (2018)

Secukinumab and hidradenitis suppurativa: Friends or foes?
por: Marasca, Claudio, et al.
Publicado: (2019)

A Case of the Co-Existence of Subcorneal Pustular Dermatosis and Pyoderma Gangrenosum and a Review of the Literature
por: Ferrillo, Maria, et al.
Publicado: (2018)

Appearances may be deceiving
por: Megna, Matteo, et al.
Publicado: (2016)

Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience
por: Scalvenzi, Massimiliano, et al.
Publicado: (2019)

Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19
por: Martora, Fabrizio, et al.
Publicado: (2023)

Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications
por: Marasca, Claudio, et al.
Publicado: (2022)

Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment
por: Napolitano, Maddalena, et al.
Publicado: (2017)

Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data
por: Ruggiero, Angelo, et al.
Publicado: (2023)

Pemphigus vulgaris and COVID‐19 vaccination: Management and treatment
por: Martora, Fabrizio, et al.
Publicado: (2022)

COVID-19, quarantine, and atopic dermatitis
por: Patruno, Cataldo, et al.
Publicado: (2020)

Safety and Efficacy of Covid-19 Vaccination in Patients Undergoing Biological Treatments for Psoriasis
por: Potestio, Luca, et al.
Publicado: (2023)

The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature
por: Cacciapuoti, Sara, et al.
Publicado: (2020)

Teledermatology: A useful tool also after COVID‐19 era?
por: Megna, Matteo, et al.
Publicado: (2022)

Long‐term results of teledermatology for acne patients during COVID‐19 pandemic
por: Villani, Alessia, et al.
Publicado: (2022)

The Role of Teledermatology During the COVID-19 Pandemic: A Narrative Review
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Letter to the editor regarding article “Yalici‐Armagan B, Tabak GH, Dogan‐Gunaydin S, Gulseren D, Akdogan N, Atakan N. Treatment of psoriasis with biologics in the early COVID‐19 pandemic: A study examining patient attitudes toward the treatment and disease course. J Cosmet Dermatol. 2021;00:1–5”
por: Potestio, Luca, et al.
Publicado: (2021)

Psoriasis Features in Patients with Inflammatory Bowel Disease
por: Napolitano, Maddalena, et al.
Publicado: (2019)

Letter to the editor regarding the article “Oguz Topal I, Kara Polat A, Zindancı İ, et al. Adherence to systemic therapy in patients with psoriasis during the COVID‐19 pandemic: A multicenter study. J Cosmet Dermatol. 2021;10.1111/jocd.14610.”
por: Potestio, Luca, et al.
Publicado: (2022)

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
por: Potestio, Luca, et al.
Publicado: (2023)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

A Case of Ofuji Disease Successfully Treated with the Combination of Low-Dose Indomethacin and Topical Tacrolimus
por: Marasca, Claudio, et al.
Publicado: (2020)

Long-Term Efficacy and Safety of Guselkumab for Moderate to Severe Psoriasis: A 3-Year Real-Life Retrospective Study
por: Megna, Matteo, et al.
Publicado: (2022)

Is It Possible to Improve Scabies Diagnosis Performance?
por: Greco, Vincenzo, et al.
Publicado: (2021)

Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study
por: Ruggiero, Angelo, et al.
Publicado: (2021)

Insulin Resistance and Skin Diseases
por: Napolitano, Maddalena, et al.
Publicado: (2015)

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2023)

Urticaria relapse after mRNA COVID‐19 vaccines in patients affected by chronic spontaneous urticaria and treated with antihistamines plus omalizumab: A single‐center experience
por: Picone, Vincenzo, et al.
Publicado: (2022)

Bimekizumab for the Treatment of Psoriasis: A Review of the Current Knowledge
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Role of Aryl Hydrocarbon Receptor Activation in Inflammatory Chronic Skin Diseases
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Effectiveness and Safety of Deucravacitinib for the Management of Psoriasis: A Review of the Current Literature
por: Potestio, Luca, et al.
Publicado: (2023)

Guselkumab, Risankizumab, and Tildrakizumab in the Management of Psoriasis: A Review of the Real-World Evidence
por: Ruggiero, Angelo, et al.
Publicado: (2022)

Ixekizumab and brodalumab indirect comparison in the treatment of moderate to severe psoriasis: Results from an Italian single‐center retrospective study in a real‐life setting
por: Megna, Matteo, et al.
Publicado: (2022)

Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication
por: Napolitano, Maddalena, et al.
Publicado: (2022)

Prevalence of Chronic Inducible Urticaria in Elderly Patients
por: Napolitano, Maddalena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a7arb1cjfqjjcpujtu058rq6i7